Please login to the form below

Not currently logged in
Email:
Password:

product withdrawal

This page shows the latest product withdrawal news and features for those working in and with pharma, biotech and healthcare.

Fertility drugs drive healthcare growth at Merck KGaA

Fertility drugs drive healthcare growth at Merck KGaA

The company put the performance in the quarter down to the withdrawal of a rival product - Ferring's Bravelle - from the US market last year because of quality issues, as well

Latest news

  • Teva suspends migraine patch on burn reports Teva suspends migraine patch on burn reports

    In addition to the suspension from sale, Teva is also carrying out a pharmacy level recall of Zecuity and patients are recommended to stop using the product straight away.

  • Vioxx 'risks can be immediate'

    its global withdrawal of the product (September 2004) when the cardiovascular side effects became apparent and supported by scientific evidence.

  • Communicable risk

    product for which there is a reasonable possibility that the product caused a response. ... to take urgent measures (product withdrawal from the market), and assessment of product risk via life cycle management.

  • Risk nationale

    Many risk management interventions were designed and implemented in reaction to new safety information, mainly in an attempt to avoid product withdrawal. ... To obtain marketing approval, firms have to provide evidence that the product is both

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Brexit implications for UK pharma legislation Brexit implications for UK pharma legislation

    on certification of clinical trials, conformity with good manufacturing practices, manufacturing inspections and, in a most ambitious deal, on product licences. ... In due course, the UK could endeavour to reach equivalence and mutual recognition

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Real world project management

    The ex-trial patients were allowed to continue access free of charge until the product was commercially available in their country. ... In contrast to this is a programme we are managing to support the global withdrawal of an oncology product.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS Just::

HAVAS Just:: is a different kind of healthcare communications agency. Our mission is to create campaigns that make people think....

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics